Cc1cccc(-c2nc3c4ccccc4n(CC(=O)Nc4cccc(F)c4)c(=O)n3n2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?